Stock listing
BOATS:SXTP 60 Degrees Pharmaceuticals, Inc. Stock
US listing (BOATS) of 60 Degrees Pharmaceuticals, Inc. · home listing NASDAQ:SXTP
Follow 60 Degrees Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SXTP
$1.01 USD +0.10 (+11.5%)
Close on Nov 3, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SXTP
- Day range
- $0.87 – $1.02 USDNov 3, 2026
- Volume
- 71,686 sharesNov 3, 2026
- Market cap
- $3.55M USDAt the close on Nov 3, 2026 · price × 3.52M shares outstanding
- 52-week range
- $0.588 – $8.62 USDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $334,428 USDMedian day 53,550 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SXTP · Home | $1.01 USD | +0.104 (+11.5%) | 71,686 | $0.931 | $1.02 | $0.87 | $0.906 | Close on Nov 3, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · NASDAQ:SXTP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.01 | +0.104 | +11.5% | $0.931 | $1.02 | $0.87 | 71,686 | |
| $0.906 | -0.034 | -3.6% | $0.948 | $0.948 | $0.827 | 46,819 | |
| $0.94 | -0.008 | -0.8% | $0.944 | $0.969 | $0.90 | 73,171 | |
| $0.948 | +0.101 | +11.9% | $0.802 | $1.00 | $0.799 | 352,946 | |
| $0.847 | +0.107 | +14.5% | $0.786 | $0.988 | $0.75 | 1,984,420 | |
| $0.74 | -0.128 | -14.7% | $0.869 | $0.872 | $0.588 | 16,269,861 | |
| $0.868 | -0.002 | -0.2% | $0.86 | $0.889 | $0.824 | 19,444 | |
| $0.87 | -0.006 | -0.7% | $0.821 | $0.93 | $0.821 | 13,100 | |
| $0.876 | -0.014 | -1.6% | $0.871 | $0.914 | $0.85 | 17,700 | |
| $0.89 | -0.032 | -3.5% | $0.941 | $0.95 | $0.87 | 24,200 | |
| $0.922 | +0.095 | +11.5% | $0.826 | $1.00 | $0.812 | 34,300 | |
| $0.827 | -0.028 | -3.3% | $0.861 | $0.90 | $0.82 | 40,300 | |
| $0.855 | -0.044 | -4.9% | $0.90 | $0.912 | $0.85 | 10,400 | |
| $0.899 | +0.019 | +2.2% | $0.88 | $0.90 | $0.835 | 37,300 | |
| $0.88 | -0.02 | -2.2% | $0.91 | $0.941 | $0.877 | 53,300 | |
| $0.90 | -0.016 | -1.7% | $0.887 | $0.942 | $0.875 | 37,500 | |
| $0.916 | -0.049 | -5.1% | $0.939 | $0.963 | $0.891 | 37,800 | |
| $0.965 | -0.008 | -0.8% | $0.96 | $0.996 | $0.91 | 41,100 | |
| $0.973 | -0.127 | -11.5% | $1.02 | $1.08 | $0.96 | 93,100 | |
| $1.10 | -0.01 | -0.9% | $1.06 | $1.16 | $1.008 | 153,800 | |
| $1.11 | -0.33 | -22.9% | $1.07 | $1.196 | $0.892 | 2,448,200 | |
| $1.44 | +0.05 | +3.6% | $1.55 | $1.66 | $1.361 | 626,000 | |
| $1.39 | +0.14 | +11.2% | $1.28 | $1.45 | $1.22 | 196,300 | |
| $1.25 | -0.08 | -6.0% | $1.29 | $1.39 | $1.23 | 137,200 | |
| $1.33 | +0.08 | +6.4% | $1.23 | $1.34 | $1.18 | 111,000 | |
| $1.25 | 0.00 | 0.0% | $1.27 | $1.30 | $1.21 | 146,500 | |
| $1.25 | +0.08 | +6.8% | $1.17 | $1.25 | $1.14 | 80,300 | |
| $1.17 | +0.02 | +1.7% | $1.16 | $1.17 | $1.12 | 35,000 | |
| $1.15 | -0.01 | -0.9% | $1.16 | $1.20 | $1.09 | 52,900 | |
| $1.16 | +0.12 | +11.5% | $1.04 | $1.16 | $1.04 | 53,800 | |
| $1.04 | +0.03 | +3.0% | $0.96 | $1.10 | $0.96 | 74,300 | |
| $1.01 | +0.054 | +5.6% | $0.98 | $1.02 | $0.94 | 24,200 | |
| $0.956 | -0.037 | -3.7% | $0.97 | $0.99 | $0.92 | 31,500 | |
| $0.993 | +0.069 | +7.5% | $0.96 | $1.04 | $0.85 | 179,900 | |
| $0.924 | +0.078 | +9.2% | $0.919 | $0.967 | $0.86 | 125,000 | |
| $0.846 | -0.053 | -5.9% | $0.90 | $0.90 | $0.84 | 61,900 | |
| $0.899 | -0.001 | -0.1% | $0.91 | $0.95 | $0.882 | 109,300 | |
| $0.90 | -0.03 | -3.2% | $0.961 | $0.961 | $0.90 | 57,800 | |
| $0.93 | -0.01 | -1.1% | $0.94 | $1.005 | $0.92 | 130,000 | |
| $0.94 | -0.037 | -3.8% | $0.98 | $1.00 | $0.93 | 30,600 | |
| $0.977 | +0.058 | +6.3% | $0.92 | $1.04 | $0.91 | 82,000 | |
| $0.919 | -0.011 | -1.2% | $0.93 | $0.989 | $0.897 | 57,800 | |
| $0.93 | -0.02 | -2.1% | $0.99 | $0.99 | $0.93 | 53,300 | |
| $0.95 | -0.07 | -6.9% | $1.03 | $1.05 | $0.90 | 105,200 | |
| $1.02 | -0.06 | -5.6% | $1.06 | $1.08 | $1.01 | 43,100 | |
| $1.08 | +0.05 | +4.9% | $1.03 | $1.09 | $1.01 | 40,700 | |
| $1.03 | -0.03 | -2.8% | $1.09 | $1.12 | $1.01 | 23,400 | |
| $1.06 | -0.02 | -1.9% | $1.08 | $1.115 | $1.05 | 46,600 | |
| $1.08 | -0.05 | -4.4% | $1.12 | $1.16 | $1.01 | 97,100 | |
| $1.13 | +0.05 | +4.6% | $1.12 | $1.13 | $1.05 | 18,700 | |
| $1.08 | -0.05 | -4.4% | $1.13 | $1.157 | $1.04 | 51,200 | |
| $1.13 | 0.00 | 0.0% | $1.15 | $1.15 | $1.09 | 17,600 | |
| $1.13 | 0.00 | 0.0% | $1.12 | $1.16 | $1.092 | 25,300 | |
| $1.13 | +0.01 | +0.9% | $1.14 | $1.162 | $1.10 | 46,100 | |
| $1.12 | +0.04 | +3.7% | $1.08 | $1.13 | $1.08 | 36,500 | |
| $1.08 | -0.115 | -9.6% | $1.19 | $1.19 | $1.02 | 94,900 | |
| $1.195 | +0.015 | +1.3% | $1.19 | $1.26 | $1.15 | 154,800 | |
| $1.18 | +0.05 | +4.4% | $1.20 | $1.20 | $1.13 | 113,700 | |
| $1.13 | 0.00 | 0.0% | $1.14 | $1.213 | $1.129 | 36,500 | |
| $1.13 | 0.00 | 0.0% | $1.13 | $1.20 | $1.12 | 95,100 | |
| $1.13 | +0.01 | +0.9% | $1.13 | $1.171 | $1.10 | 40,200 | |
| $1.12 | -0.03 | -2.6% | $1.15 | $1.19 | $1.08 | 46,700 | |
| $1.15 | -0.07 | -5.7% | $1.21 | $1.26 | $1.14 | 48,500 | |
| $1.22 | -0.01 | -0.8% | $1.25 | $1.28 | $1.116 | 95,600 | |
| $1.23 | +0.07 | +6.0% | $1.13 | $1.23 | $1.13 | 87,700 | |
| $1.16 | -0.01 | -0.9% | $1.18 | $1.26 | $1.101 | 81,200 |
- Ticker
- BOATS:SXTP
- Asset type
- Stock
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome
Latest deck · Oct 23, 2026
2026 ILADS Annual Scientific Conference
Conference · 29 slides
Latest news
60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome
Oct 28, 2026
Closed $0.847 (+14.5%) on Oct 28, 2026
60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients
Oct 27, 2026
Closed $0.74 (-14.7%) on Oct 27, 2026
60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
Oct 6, 2026
Closed $1.11 (-22.9%) on Oct 6, 2026
60 Degrees Pharmaceuticals and Exyn Technologies Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Oct 2, 2026
Closed $1.39 (+11.2%) on Oct 2, 2026
60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar
Oct 1, 2026
Closed $1.25 (-6.0%) on Oct 1, 2026
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026
Closed $0.93 (-2.1%) on Sep 3, 2026
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
Aug 17, 2026
Closed $1.08 (-9.6%) on Aug 17, 2026
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
Jul 30, 2026
Closed $1.25 (-16.1%) on Jul 30, 2026
Financings
Private placement of common stock (or pre-funded warrants) with series A and series B warrants
Jul 30, 2026
Announced: about US$1M · US$1.74 a share · Warrants at US$1.49 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Decks
2026 ILADS Annual Scientific Conference
Conference · 29 slides · Oct 23, 2026
Technical Presentation (October 2026)
Technical · 18 slides · Oct 6, 2026
H.C. Wainwright Presentation September 2026
Conference · 19 slides · Sep 8, 2026
Investor Presentation (July 2026)
Investor deck · 30 slides · Jul 20, 2026
60 Degrees Pharmaceuticals, Inc. on 6ix
- News releases
- 26 in the last 12 months · 90 in all · newest Oct 28, 2026 · oldest 2023
- Decks
- 7 decks · latest Oct 23, 2026
Where 60 Degrees Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SXTP · Home listing | NASDAQ | United States | USD |
| BOATS:SXTP · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about 60 Degrees Pharmaceuticals, Inc.